Bartlett Linda, Cantor David, Lynam Pamela, Kaur Gurpreet, Rawlins Barbara, Ricca Jim, Tripathi Vandana, Rosen Heather E
Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, United States of America (USA).
ICF International, Rockville, USA .
Bull World Health Organ. 2015 Nov 1;93(11):759-67. doi: 10.2471/BLT.14.142604. Epub 2015 Aug 31.
To assess the quality of facility-based active management of the third stage of labour in Ethiopia, Kenya, Madagascar, Mozambique, Rwanda and the United Republic of Tanzania.
Between 2009 and 2012, using a cross-sectional design, 2317 women in 390 health facilities were directly observed during the third stage of labour. Observers recorded the use of uterotonic medicines, controlled cord traction and uterine massage. Facility infrastructure and supplies needed for active management were audited and relevant guidelines reviewed.
Most (94%; 2173) of the women observed were given oxytocin (2043) or another uterotonic (130). The frequencies of controlled cord traction and uterine massage and the timing of uterotonic administration showed considerable between-country variation. Of the women given a uterotonic, 1640 (76%) received it within three minutes of the birth. Uterotonics and related supplies were generally available onsite. Although all of the study countries had national policies and/or guidelines that supported the active management of the third stage of labour, the presence of guidelines in facilities varied across countries and only 377 (36%) of 1037 investigated providers had received relevant training in the previous three years.
In the study countries, quality and coverage of the active management of the third stage of labour were high. However, to improve active management, there needs to be more research on optimizing the timing of uterotonic administration. Training on the use of new clinical guidelines and implementation research on the best methods to update such training are also needed.
评估埃塞俄比亚、肯尼亚、马达加斯加、莫桑比克、卢旺达及坦桑尼亚联合共和国基于医疗机构的第三产程积极管理的质量。
2009年至2012年期间,采用横断面设计,在390家医疗机构对2317名产妇的第三产程进行直接观察。观察人员记录宫缩剂的使用、控制脐带牵拉及子宫按摩情况。对积极管理所需的医疗机构基础设施和物资进行审计,并审查相关指南。
观察的产妇中,大多数(94%;2173例)使用了缩宫素(2043例)或其他宫缩剂(130例)。控制脐带牵拉和子宫按摩的频率以及宫缩剂给药时间在不同国家间存在显著差异。在使用宫缩剂的产妇中,1640例(76%)在分娩后3分钟内用药。宫缩剂及相关物资一般在现场可得。尽管所有研究国家都有支持第三产程积极管理的国家政策和/或指南,但各国家医疗机构中指南的存在情况各不相同,在1037名接受调查的医护人员中,只有377名(36%)在过去三年接受过相关培训。
在研究国家,第三产程积极管理的质量和覆盖率较高。然而,为改善积极管理,需要对优化宫缩剂给药时间进行更多研究。还需要开展关于使用新临床指南的培训以及关于更新此类培训的最佳方法的实施研究。